Thrombopoietin: Expression of its receptor MPL and proliferative effects on leukemic cells

Leukemia

Volumn 10, Issue 9, 1996, Pages 1405-1421

  Drexler, H G ^a   Quentmeier, H ^a  

^a LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

Author keywords

Cell lines; Cytokine; Leukemia; MPL; Receptor; TPO

Indexed keywords

CYTOKINE RECEPTOR; MESSENGER RNA; THROMBOPOIETIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; APLASTIC ANEMIA; CELL PROLIFERATION; CHRONIC MYELOMONOCYTIC LEUKEMIA; HUMAN; HUMAN CELL; LEUKEMIA CELL; LIGAND BINDING; MEGAKARYOPOIESIS; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; SEQUENCE HOMOLOGY; THROMBOCYTOPOIESIS;

EID: 0029760127     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (136)

1. Callard R, Gearing A (eds). The Cytokine Facts Book. Academic Press: London, 1994.
2. Nicola NA (ed). Guidebook to Cytokines and their Receptors. Oxford University Press: Oxford, 1994.
3. Moore MAS. Haemopoietic growth factor interactions: In vitro and in vivo preclinical evaluation. Cancer Surv 1990; 9: 7-80.
4. Cosman D. The hematopoietin receptor superfamily. Cytokine 1993; 5: 95-106.
5. Long MW. Cyclins and cell division kinases in megakaryocytic endomitosis. Comptes Rend Acad Sci 1995; 318: 649-654.
6. McDonald TP. Thrombopoietin: its biology, purification, and characterization. Exp Hematol 1988; 16: 201-205.
7. Murphy MJ. Megakaryocyte colony-stimulating factor and thrombopoiesis. Hematol Oncol North Am 1989; 3: 465-478.
8. Broudy VC, Kaushansky K. Thrombopoietin, the c-mpl ligand, is a major regulator of platelet production. J Leuk Biol 1995; 57: 719-725.
9. Gordon MS, Hoffman R. Growth factors affecting human thrombocytopoiesis: potential agents for the treatment of thrombocytopenia. Blood 1992; 80: 302-307.
10. Hoffman R. Regulation of megakaryocytopoiesis. Blood 1989; 74: 1196-1212.
11. Levin J. An overview of thrombopoietin with a historical perspective. Comptes Rend Acad Sci 1995; 318: 609-618.
12. Lok S, Foster C. The structure, biology and potential therapeutic applications of recombinant thrombopoietin. Stem Cells 1994; 12: 586-598.
13. Mazur EM. Megakaryocytopoiesis and platelet production: a review. Exp Hematol 1987; 15: 340-350.
14. Vainchenker W, Kieffer N. Human megakaryocytopoiesis: in vitro regulation and characterization of megakaryocyte precursor cells by differentiation markers. Blood Rev 1988; 2: 102-107.
15. Williams N. Is thrombopoietin interleukin 6? Exp Hematol 1991; 19: 714-718.
16. Williams N, Jackson H, Walker F, Oon SH. Multiple levels of regulation of megakaryocytopoiesis. Blood Cells 1989; 15: 123-133.
17. Kelemen E. Specific thrombopoietin cloned and sequenced - with personal retrospect and clinical prospects. Leukemia 1995; 9: 1-2.
18. Metcalf D. Thrombopoietin-at last. Nature 1994; 369: 519-520.
19. Souyri M, Vigon I, Penciolelli JF, Heard JM, Tambourin P, Wendling F. A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell 1990; 63: 1137-1147.
20. Wendling FL, Varlet P, Charon M, Tambourin P. MPLV: a murine retroviral complex inducing an acute myeloproliferative leukemic disorder in adult mice. Virology 1986; 149: 242-246.
21. Penciolelli JF, Wendling FL, Robert-Lezenes J, Barque JP, Tambourin P, Gisselbrecht S. Genetic analysis of the myeloproliferative leukemia virus, a novel acute leukemogenic replication-defective retrovirus. J Virol 1987; 61: 579-583.
22. Bénit L, Courtois G, Charon M, Varlet P, Dusanter-Fourt I, Gisselbrecht S. Characterization of mpl cytoplasmic domain sequences required for myeloproliferative leukemia virus pathogenicity. Virology 1994; 68: 5270-5274.
23. Fichelson S, Vigon I, Dusanter I, Charon M, Velu T, Baillou C, Gisselbrecht S, Lemoine FM. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor. J Immunol 1995; 154: 1577-1586.
24. Wendling F, Vigon I, Souyri M, Tambourin P. Myeloid progenitor cells transformed by the myeloproliferative leukemia virus proliferate and differentiate in vitro without addition of growth factors. Leukemia 1989; 3: 475-480.
25. Wendling F, Penciolelli JF, Charon M, Tambourin P. Factor-independent erythropoietic progenitor cells in leukemia induced by the myeloproliferative leukemia virus. Blood 1989; 73: 1161-1167.
26. Alexander WS, Dunn AR. Structure and transcription of the genomic locus ending murine c-Mpl, a receptor for thrombopoietin. Oncogene 1995; 10: 795-803.
27. Mignotte V, Vogin I, de Crèvecoeur EB, Roméo PH, Lemarchandel V, Chrétien S. Structure and transcription of the human c-mpl gene (MPL). Genomics 1994; 20: 5-12.
28. Skoda RC, Seldin DC, Chiang MK, Peichel CL, Vogt TF, Leder P. Murine c-mpl: a member of the hematopoietic growth factor receptor superfamily that tranduces a proliferative signal. EMBO J 1993; 12: 2645-2653.
29. Vigon I, Mornon JP, Cocault L, Mitjavila MT, Tambourin P, Gisselbrecht S, Souyri M. Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: Identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci USA 1992; 89: 5640-5644.
30. Vigon I, Florindo C, Fichelson S, Guenet JL, Mattel MG, Souyri M, Cosman D, Gisselbrecht S. Characterization of the murine MpI proto-oncogene, a member of the hematopoietic cytokine receptor family: molecular cloning, chromosomal location and evidence for a function in cell growth. Oncogene 1993; 8: 2607-2615.
31. Le Coniat M, Souyri M, Vigon I, Wendling F, Tambourin P, Berger R. The human homolog of the myeloproliterative virus maps to chromosome band 1p34. Hum Genet 1989; 83: 194-196.
32. Columbyova L, Loda M, Scadden DT. Thrombopoietin receptor expression in human cancer cell lines and primary tissues. Cancer Res 1995; 55: 3509-3512.
33. Methia N, Louache F, Vainchenker W, Wendling F. Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood 1993; 82: 1395-1401.
34. Berardi AC, Wang A, Levine JD, Lopez P, Scadden DT. Functional isolation and characterization of human hematopoietic stem cells. Science 1994; 267: 104-108.
35. Baumann H, Gearing D, Ziegler SF. Signaling by the cytoplasmic domain of hematopoietin receptors involves two distinguishable mechanisms in hepatic cells. J Biol Chem 1994; 269: 16297-16304.
36. Debili N, Wendling F, Cosman D, Titeux M, Florindo C, Dusanter-Fourt I, Schooley K, Methia N, Charon M, Nador R, Bettaieb A, Vainchenker W. The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood 1995; 85: 391-401.
37. Gurney AL, Carver-Moore K, de Sauvage FJ, Moore MW. Thrombocytopenia in c-mpl-deficient mice. Science 1994; 265: 1445-1447.
38. Alexander WS, Roberts AW, Nicola NA, Li RL, Metcalf D. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-mpl. Blood 1996; 87: 2162-2170.
39. Methia N, Debili N, Titeux M, Vainchenker W, Wendling F. From the v-mpl oncogene to thrombopoietin. Comptes Rend Acad Sci 1995; 318: 479-482.
40. de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, Henzel WJ, Wong SC, Kuang WJ, Oles KJ, Hultgren B, Solberg LA Jr, Goeddel DV, Eaton DL. Stimulation of megakaryocytopoiesis and thrombopoiesis by the C-Mpl ligand. Nature 1994; 369: 533-538.
41. Gurney AL, Kuang WJ, Xie MH, Malloy BE, Eaton DL, de Sauvage FJ. Genomic structure, chromosomal localization, and conserved alternative splice forms of thrombopoietin. Blood 1995; 85: 981-988.
42. Bartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F, Chang MS, Samal B, Nichol JL, Swift S, Johnson MJ, Hsu RY, Parker VP, Suggs S, Skrine JD, Merewether LA, Clogston C, Hsu E, Hokom MM, Hornkohl A, Choi E, Pangelinan M, Sun Y, Mar V, McNinch J, Simonet L, Jacobsen F, Xie C, Shutter J, Chute H, Basu R, Selander L, Trollinger D, Sieu L, Padilla D, Trail G, Elliott G, Izumi R, Covey T, Crouse J, Garcia A, Xu W, Del Castillo J, Biron J, Cole S, Hu MCT, Pacifici R, Ponting I, Saris C, Wen D, Yung YP, Lin H, Bosselman RA. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994; 77: 1117-1124.
43. Hunt P, Li YS, Nichol JL, Hokom MM, Bogenberger JM, Swift SE, Skrine JD, Hornkohl AC, Lu H, Clogston C, Merewether LA, Johnson MJ, Parker V, Knudten A, Farese A, Hsu RY, Garcia A, Stead R, Bosselman RA, Bartley TD. Purification and biologic characterization of plasma-derived megakaryocyte growth and development factor. Blood 1995; 86: 540-547.
44. Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ, Grant FJ, Heipel MD, Burkhead SK, Kramer JM, Bell LA, Sprecher CA, Blumberg H, Johnson R, Prunkard D, Ching AFT, Mathewes SL, Bailey MC, Forstrom JW, Buddle MM, Osborn SG, Evans SJ, Sheppard PO, Presnell SR, O'Hara PJ, Hagen FS, Roth GJ, Foster DC. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994; 369: 565-568.
45. Foster DC, Sprecher CA, Grant FJ, Kramer JM, Kuijper JI, Holly RD, Whitmore TE, Heipel MD, Bell LA, Ching AFT, McGrane V, Hart C, O'Hara PJ, Lok S. Human thrombopoietin: gene structure, cDNA sequence, expression, and chromosomal localization. Proc Natl Acad Sci USA 1994; 91: 13023-13027.
46. Ogami K, Shimada Y, Sohma Y, Akahori H, Kato T, Kawamura K, Miyazaki H. The sequence of a rat cDNA encoding thrombopoietin. Gene 1995; 158: 309-310.
47. Kato T, Ogami K, Shimada Y, Iwamatsu A, Sohma Y, Akahori H, Horie K, Kokubo A, Kudo Y, Maeda E, Kobayashi K, Ohashi H, Ozawa T, Inoue H, Kawamura K, Miyazaki H. Purification and characterization of thrombopoietin. J Biochem 1995; 118: 229-236.
48. Sohma Y, Akahori H, Seki N, Hori TA, Ogami K, Kato T, Shimada Y, Kawamura K, Miyazaki H. Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEBS Lett 1994; 353: 57-61.
49. Kuter DJ, Beeler DL, Rosenberg RD. The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci USA 1994; 91: 11104-11108.
50. Chang MS, McNinch J, Basu R, Shutter J, Hsu RY, Perkins C, Mar V, Suggs S, Welcher A, Li L, Lu H, Bartley T, Hunt P, Martin F, Samal B, Bogenberger J. Cloning and characterization of the human megakaryocyte growth and development factor (MGDF) gene. J Biol Chem 1995; 270: 511-514.
51. Wada T, Nagata Y, Nagahisa H, Okutomi K, Ha SH, Ohnuki T, Kanaya T, Matsumura M, Todokoro K. Characterization of the truncated thrombopoietin variants. Biochem Biophys Res Commun 1995; 213: 1091-1098.
52. Suzukawa K, Satoh H, Taniwaki M, Yokota J, Morishita K. The human thrombopoietin gene is located on chromosome 3q26.33-q27, but is not transcriptionally activated in leukemia cells with 3q21 and 3q26 abnormalities (3q21q26 syndrome). Leukemia 1995; 9: 1328-1331.
53. Chang MS, Hsu RY, McNinch J, Copeland NG, Jenkins NA. The gene for murine megakaryocyte growth and development factor (thrombopoietin), Tpo, is located on mouse chromosome 16. Genomics 1995; 26: 636-637.
54. Kaushansky K, Broudy VC, Lin N, Jorgensen MJ, McCarty J, Fox N, Zucker-Franklin D, Lofton-Day C. Thrombopoietin, the Mpl ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci USA 1995; 92: 3234-3238.
55. Kaushansky K, Lok S, Holly RD, Broudy VC, Lin N, Bailey MC, Forstrom JW, Buddle MM, Oort PJ, Hagen FS, Roth GJ, Papayannopoulou T, Foster DC. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 1994; 369: 568-571.
56. Nichol JL, Hokom MM, Hornkohl A, Sheridan WP, Ohashi H, Kato T, Li YS, Bartley TD, Choi E, Bogenberger J, Skrine JD, Knudten A, Chen J, Trail G, Sleeman L, Cole S, Grampp G, Hunt P. Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia. J Clin Invest 1995; 95: 2973-2978.
57. Wendling F, Maraskovsky E, Debili N. Florindo C, Teepe M, Titeux M, Methia N, Breton-Gorius J, Cosman D, Vainchenker W. C-Mpl ligand is a humoral regulator of megakaryo-cytopoiesis. Nature 1994; 369: 571-574.
58. Zeigler FC, de Sauvage F, Widmer HR, Keller GA, Donahue C, Schreiber RD, Malloy B, Hass P, Eaton D, Matthews W. In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood 1994; 84: 4045-4052.
59. Choi ES, Hokom M, Bartley T, Li YS, Ohashi H, Kato T, Nichol JL, Skrine J, Knudten A, Chen J, Hornkohl A, Grampp G, Sleeman L, Cole S, Trail G, Hunt P. Recombinant human megakaryocyte growth and development factor (rhuMGDF), a ligand for c-Mpl, produces functional human platelets In vitro. Stem Cells 1995; 13: 317-322.
60. Guerriero R, Testa U, Gabbianelli M, Mattia G, Montesoro E, Macioce G, Pace A, Ziegler B, Hassan HJ, Peschle C. Unilineage megakaryocytic proliferation and differentiation of purified hematopoietic progenitors in serum-free liquid culture. Blood 1995; 86: 3725-3736.
61. Nishihira H, Toyoda Y, Miyazaki H, Kigasawa H, Ohsaki E. Growth of macroscopic human megakaryocytic colonies from cord blood in culture with recombinant human thrombopoietin (c-mpl ligand) and the effects of gestational age on frequency of colonies. Br J Haematol 1996; 92: 23-28.
62. Farese AM, Hunt P, Boone T, MacVittie TJ. Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates. Blood 1995; 86: 54-59.
63. Fibbe WE, Heemskerk DPM, Laterveer L, Pruijt JFM, Foster D, Kaushansky K, Willemze R. Accelerated reconstitution of platelets and erythrocytes after syngeneic transplantation of bone marrow cells derived from thrombopoietin pretreated donor mice. Blood 1995; 86: 3308-3313.
64. Ulich TR, del Castillo J, Yin S, Swift S, Padilla D, Senaldi G, Bennett L, Shutter J, Bogenberger J, Sun D, Samal B, Shimamoto G, Lee R, Steinbrink R, Boone T, Sheridan WT, Hunt P. Megakaryocyte growth and development factor ameliorates carboplatin-induced thrombocytopenia in mice. Blood 1995; 86: 971-976.
65. Yan XQ, Lacey D, Fletcher F, Hartley C, McElroy P, Sun Y, Xia M, Mu S, Saris C, Hill D, Hawley RG, McNiece IK. Chronic exposure to retroviral vector encoded MDGF (mpl-/ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice. Blood 1995; 86: 4025-4033.
66. Banu N, Wang JF, Deng B, Groopman JE, Avraham H. Modulation of megakaryocytopoiesis by thrombopoietin: the C-Mpl ligand. Blood 1995; 86: 1331-1338.
67. Broudy VC, Lin NL, Kaushansky K. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood 1995; 85: 1719-1726.
68. Schattner M, Lefebvre P, Mingolelli SS, Goolsby CL, Rademaker A, White JG, Foster D, Green D, Cohen I. Thrombopoietin-stimulated ex vivo expansion of human bone marrow megakaryocytes. Stem Cells 1996; 14: 207-214.
69. Debili N, Wendling F, Katz A, Guichard J, Breton-Gorius J, Hunt P, Vainchenker W. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood 1995; 86: 2516-2525.
70. Murray LJ, Mandich D, Bruno E, DiGiusto RK, Fu WC, Sutherland DR, Hoffman R, Tsukamoto A. Fetal bone marrow CD34(+)CD41(+) cells are enriched for multipotent hematopoietic progenitors, but not for pluripotent stem cells. Exp Hematol 1996; 24: 236-245.
71. Kaushansky K, Lin N, Grossmann A, Humes J, Sprugel KH, Broudy VC. Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice. Exp Hematol 1996; 24: 265-269.
72. Kaushansky K, Broudy VC, Grossman A, Humes J, Lin N, Ren HP, Bailey MC, Papayannopoulou T, Forstrom JW, Sprugel KH. Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy. J Clin Invest 1995; 96: 1683-1687.
73. Kobayashi M, Laver JH, Kato T, Miyazaki H, Ogawa M. Recombinant human thrombopoietin (Mpl ligand) enhances proliferation of erythroid progenitors. Blood 1995; 86: 2494-2499.
74. Papayannopoulou T, Brice M, Farrer D, Kaushansky K. Insights into the cellular mechanisms of erythropoietin-thrombopoietin synergy. Exp Hematol 1996; 24: 660-669.
75. Ballmeier M, Bogenberger J, Shutter J, Welcher A, Tidow N, König A, Wilken A, Schweinitz DV, Hadam M, Welte K. Analysis of expression of megakaryocyte growth and development factor mRNA in various human normal and malignant tissues. Blood 1994; 84: 241a.
76. Shimada Y, Kato T, Ogami K, Horie K, Kokubo A, Kudo Y, Maeda E, Sohma Y, Akahori H, Kawamura K, Miyazaki H. Production of thrombopoietin (TPO) by rat hepatocytes and hepatoma cell lines. Exp Hematol 1995; 23: 1388-1396.
77. Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood 1995; 86: 419-431.
78. Nagahisa H, Nagata Y, Ohnuki T, Osada M, Nagasawa T, Abe T, Todokoro K. Bone marrow stromal cells product thrombopoietin and stimulate megakaryocyte growth and maturation but suppress proplatelet formation. Blood 1996; 87: 1309-1316.
79. De Sauvage FJ, Carver-Moore K, Luoh SM, Ryan A, Dowd M, Eaton DL, Moore MW. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med 1996; 183: 651-656.
80. Kuter DJ, Rosenberg RD. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 1995; 85: 2720-2730.
81. McCarty JM, Sprugel KH, Fox NE, Sabath DE, Kaushansky K. Murine thrombopoietin mRNA levels are modulated by platelet count. Blood 1995; 86: 3668-3675.
82. Fielder PJ, Gurney AL, Stefanich E, Marian M, Moore MW, Carver-Moore K, de Sauvage FJ. Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood 1996; 87: 2154-2161.
83. Stoffel R, Wiestner A, Skoda RC. Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 1996; 87: 567-573.
84. Shivdasani RA, Rosenblatt MF, Zucker-Franklin D, Jackson CW, Hunt P, Saris CJ, Orkin SH. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 1995; 81: 695-704.
85. Belka C, Brach MA, Herrmann F. The role of tyrosine kinases and their substrates in signal transmission of hematopoietic growth factors: a short review. Leukemia 1995; 9: 754-761.
86. Schindler C, Darnell JE. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Ann Rev Biochem 1995; 64: 621-651.
87. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Silvennoinen O. Signalling through the hematopoietic cytokine receptors. Ann Rev Immunol 1995; 13: 369-398.
88. Dorsch M, Fan PD, Bogenberger J, Goff SP. TPA and IL-3 induce overlapping but distinct protein tyrosine phosphorylation in a myeloid precursor cell line. Biochem Biophys Res Commun 1995; 214: 424-431.
89. Drachmen JC, Griffin JD, Kaushansky K. The c-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, She, and c-Mpl. J Biol Chem 1995; 270: 4979-4982.
90. Gurney AL, Wong SC, Henzel WJ, de Sauvage FJ. Distinct regions of c-Mpl cytoplasmic domain are coupled to the JAK-STAT signal transduction pathway and She phosphorylation. Proc Natl Acad Sci USA 1995; 92: 5292-5296.
91. Kojima H, Hamazaki Y, Nagata Y, Todokoro K, Nagasawa T, Abe T. Modulation of platelet activation in vitro by thrombopoietin. Thrombosis Haemostatis 1995; 74: 1541-1545.
92. Miyakawa Y, Oda A, Druker BJ, Kato T, Miyazaki H, Handa M, Ikeda Y. Recombinant thrombopoietin induces rapid protein tyrosine phosphorylation of Janus kinase 2 and Shc in human blood platelets. Blood 1995; 86: 23-27.
93. Morella KK, Bruno E, Kumaki S, Lai CF, Fu J, Wang HM, Murray L, Hoffman R, Timour M, Bénit L, Gisselbrecht S, Zhuang H, Wojchowski DM, Baumann H, Gearing DP. Signal transduction by the receptors for thrombopoietin (c-mpl) and interleukin-3 in hematopoietic and nonhematopoietic cells. Blood 1995; 86: 557-571.
94. Pallard C, Gouilleux F, Bénit L, Cocault L, Souyri M, Levy D, Groner B, Gisselbrecht S, Dusanter-Fourt I. Thrombopoietin activates a STAT5-like factor in hematopoietic cells. EMBO J 1995; 14: 2847-2856.
95. Sattler M, Durstin MA, Frank DA, Okuda K, Kaushansky K, Salgia R, Griffin JD. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases. Exp Hematol 1995; 23: 1040-1048.
96. Tortolani PJ, Johnston JA, Bacon CM, McVicar DW, Shimosaka A, Linnekin D, Longo DL, O'Shea JJ. Thrombopoietin induces tyrosine phosphorylation and activation of the Janus kinase, JAK2. Blood 1995; 85: 3444-3451.
97. Bacon CM, Tortolani PJ, Shimosaka A, Rees RC, Longo DL, O'Shea JJ. Thrombopoietin (TPO) induces tyrosine phosphorylation and activation of STAT5 and STAT3. FEBS Lett 1995; 370: 63-68.
98. Yamada M, Komatsu N, Okada K, Kato T, Miyazaki H, Miura Y. Thrombopoietin induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in a human thrombopoietin-dependent cell line. Biochem Biophys Res Commun 1995; 217: 230-237.
99. Nagata Y, Nagahisa H, Aida Y, Okutomi K, Nagasawa T, Todokoro K. Thrombopoietin induces megakaryocyte differentiation in hematopoietic progenitor FDC-P2 cells. J Biol Chem 1995; 270: 19673-19675.
100. Aster RH. What makes platelets go? The cloning of thrombopoietin. Transfusion 1995; 35: 1-3.
101. Groopman JE. Capturing the unicorn. Curr Biol 1994; 4: 1016-1018.
102. Kaushansky K. Thrombopoietin: the primary regulator of megakaryocyte and platelet production. Thrombosis Haemotasis 1995; 74: 521-525.
103. Kaushansky K. Thrombopoietin: basic biology, clinical promise. Int J Hematol 1995; 62: 7-15.
104. Kaushansky K. The mpl ligand: molecular and cellular biology of the critical regulator of megakaryocyte development. Stem Cells 1994; 12 (Suppl. 1): 91-97.
105. Ogden JE. Thrombopoietin: the erythropoietin of platelets. Trends Biotechnol 1994; 12: 389-390.
106. Schick BP. Hope for treatment of thrombocytopenia. New Engl J Med 1994; 331: 875-876.
107. Vigon I, Dreyfus F, Melle J, Viguié F, Ribrag V, Cocault L, Souyri M, Gisselbrecht S. Expression of the c-mpl proto-oncogene in human hematopoietic malignancies. Blood 1993; 82: 877-883.
108. Bouscary D, Prudhomme C, Quesnel B, Melle J, Picard F, Dreyfus F. c-mpl expression in hematologic disorders. Leuk Lymphoma 1995; 17: 19-26.
109. Bouscary D, Preudhomme C, Ribrag V, Melle J, Viguié F, Picard F, Guesnu M, Fenaux P, Gisselbrecht S, Dreyfus F. Prognostic value of c-mpl expression in myelodysplastic syndromes. Leukemia 1995; 9: 783-788.
110. Matsumura I, Kanakura Y, Kato T, Ikeda H, Ishikawa J, Horikawa Y, Hashimoto K, Moriyama Y, Tsujimura T, Nishiura T, Miyazaki H, Matsuzawa Y. Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin. Blood 1995; 86: 703-709.
111. Matsumura I, Kanakura Y, Ikeda H, Ishikawa J, Yoshida H, Horikawa Y, Nishiura T, Tahara T, Kato T, Miyazaki H, Matsuzawa Y. Coexpression of thrombopoietin and c-mpl genes in human acute myeloblastic leukemia cells. Leukemia 1996; 10: 91-94.
112. Fontenay-Roupie M, Bouscary D, Melle J, Picard F, Guesnu M, Dreyfus F. Thrombopoietin expression in myelodysplastic syndromes. Hematol Cell Ther 1996; 38: 151.
113. Li Y, Hetet G, Kiladjian JJ, Gardin C, Grandchamp B, Briere J. Proto-oncogene c-mpl is involved in spontaneous megakaryocytopoiesis in myeloproliferative disorders. Br J Haematol 1996; 92: 60-66.
114. Bernstein SH, Baer MR, Stewar C, Slack JL, Lawrence D, Herzig GP, Bloomfield CD, Wetzler M. Expression of the c-mpl receptor on leukemic blasts from patients with acute myeloid leukemia (AML). Blood 1995; 86: 45a.
115. Quentmeier H, Zaborski M, Graf G, Ludwig WD, Drexler HG. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cell lines. Leukemia 1996; 10: 297-310.
116. Fujie H, Tsuchiya S, Itano M, Minegishi M, Morita S, Ohashi Y, Ishii N, Konno T. Proliferation of a GM-CSF dependent megakaryoblastic leukemia cell line, M-MOK, is induced by thrombopoietin, with synergistic effects of the stem cell factor. Leukemia (submitted).
117. Graf G, Dehmel, U, Drexler HG. Expression of thrombopoietin and thrombopoietin receptor MPL in human leukemia-lymphoma and solid tumor cell lines. Leuk Res (in press).
118. Drexler HG, Gignac SM, Minowada J. Hematopoietic cell lines. In: Hay RJ, Park JG, Gazdar A (eds). Atlas of Human Tumor Cell Lines. Academic Press: Orlando, 1994, pp 213-250.
119. Drexler HG, MacLeod RAF, Borkhardt A, Janssen JWG. Recurrent chromosomal translocations and fusion genes in leukemia-lymphoma cell lines. Leukemia 1995; 9: 480-500.
120. Drexler HG, Dirks W, MacLeod RAF, Quentmeier H, Steube K (eds). DSM Catalogue of Human and Animal Cell Lines, 5th edn, Braunschweig, Germany, 1995.
121. Lauria F, Bagnara GP, Rondelli D, Raspadori D, Strippoli P, Bosni L, Ventura MA, Montanaro LL, Bubola G, Tura S, Broudy VC. Cytofluorimetric and functional analysis of c-kit receptor in acute leukemia. Leuk Lymphoma 1995; 18: 451-456.
122. Hino M, Nishizawa Y, Tagawa S, Yamane T, Morii H, Tatsumi N. Constitutive expression of the thrombopoietin gene in a human hepatoma cell line. Biochem Biophys Res Commun 1995; 217: 475-481.
123. Fontenay-Roupie M, Picard F, Casadevall N, Squiban P, Botella A, Melle J, Dreyfus F, Hermine O, Bouscary D. Thrombopoietin effects on the in vitro proliferation of acute myeloblastic leukemia and myelodysplasia-deriving cells. Blood 1995; 86: 11a.
124. Fontenay-Roupie M, Picard F, Casadevall N, Valensi F, Botella A, Melle J, Dreyfus F, Hermine O, Bouscary D. Induction by thrombopoietin of in vitro proliferation of acute myeloblastic leukemias and myelodysplastic syndromes-deriving cells. Hematol Cell Ther 1996; 38: 157.
125. Slack JL, Baer MR, Bernstein SH, Stewart C, Lawrence D, Herzig GP, Bloomfield CD, Wetzler M. Acute myeloid leukemia (AML) blast cell proliferation and differentiation in response to megakaryocyte growth and development factor (MGDF). Blood 1995; 86: 520a.
126. Hirai H, Shimazaki C, Goto H, Inaba T, Sumikuma T, Kikuta T, Sudo Y, Yamagata N, Ashihara E, Fujita N, Hibi S, Ito E, Nakagawa M. Effects of recombinant human thrombopoietin on the proliferation of acute myeloblastic leukemia and transient abnormal myelopoiesis cells. Blood 1995; 86: 667a.
127. Piacibello W, Sanavio F, Garetto L, Severino A, Fubini L, Stacchini A, Dragonetti G, Aglietta M. The effect of human megakaryocyte growth and development factor (MGDF) on human myeloid leukemia cell growth. Blood 1995; 86: 45a.
128. McDonald TP, Wendling F, Vainchenker W, McCarty JM, Jorgenson MJ, Kaushansky K. Thrombopoietin from human embryonic kidney cells is the same factor as c-mpl-ligand. Blood 1995; 85: 292-294.
129. Salgado F, Fischer E, Kikly K, Pelus LM, Erickson-Miller C. Megakaryocytic differentiation of M-07e and HEL cell-lines but not of K562 or UT7-Epo cell-lines induced by thrombopoietin. Blood 1995; 86: 366a.
130. Morgan DA, Soslau G, Brodsky I. Differential effects of thrombopoietin (mpl) on cell lines MB-02 and HU-3 derived from patients with megakaryoblastic leukemia. Blood 1994; 84: 330a.
131. Pobboravsky KN, Brennan JK. Interleukin-1 and megakaryocyte growth and development factor (MGDF) stimulate proliferation in the human megakaryoblastic cell line UT-7. Blood 1995; 86: 678a.
132. Komatsu N, Kunitama M, Yamada M, Furukawa Y, KatoT, Miyazaki H, Eguchi M, Miura Y. Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO. Blood 1996; 87: 4552-4560.
133. Morgan DA, Class R, Soslau G, Brodsky I. Thrombopoietin (TPO) induces bi-potential HU-3 cell line to lineage commitment with enhancement of megakaryocyte antigen expression and loss of erythroid potential. Blood 1995; 86: 904a.
134. Lowe J, Lee P, Fei D, Meng G, Wong WL, Cohen B, Martin T, Morgan DA. Bioassay for TPO activity in human serum using megakaryoblastic HU-3 cell line. Blood 1995; 86: 903a.
135. Page LA, Thorpe R, Mire-Sluis AR. A sensitive human cell line based immunoassay for thrombopoietin/megakaryocyte growth and development factor. Cytokine 1996; 8: 66-69.
136. Porteu F, Rouyez MC, Cocault L, Benit L, Charon M, Picard F, Gisselbrecht S, Souyri M, Dusanter-Fourt I. Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin. Mol Cell Biol 1996; 16: 2473-2482.